IRIS
CASSANI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.485
AS - Asia 1.362
EU - Europa 852
SA - Sud America 214
AF - Africa 65
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.410
CN - Cina 431
SG - Singapore 409
HK - Hong Kong 187
RU - Federazione Russa 180
VN - Vietnam 165
BR - Brasile 157
IE - Irlanda 151
DE - Germania 125
IT - Italia 110
FR - Francia 73
FI - Finlandia 59
GB - Regno Unito 46
ZA - Sudafrica 38
IN - India 35
CA - Canada 32
MX - Messico 28
AR - Argentina 26
BD - Bangladesh 24
IQ - Iraq 16
JP - Giappone 14
PL - Polonia 14
AT - Austria 11
MA - Marocco 11
NL - Olanda 11
UA - Ucraina 11
ES - Italia 10
SE - Svezia 10
CL - Cile 8
ID - Indonesia 8
PH - Filippine 8
MY - Malesia 7
TR - Turchia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CO - Colombia 6
PK - Pakistan 6
PT - Portogallo 6
SA - Arabia Saudita 6
VE - Venezuela 6
EC - Ecuador 5
JO - Giordania 5
LT - Lituania 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
JM - Giamaica 3
LV - Lettonia 3
AL - Albania 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
TM - Turkmenistan 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.981
Salva come PNG Salva come JPEG
Città #
Singapore 216
San Jose 206
Hong Kong 184
Dublin 150
Dallas 146
Ashburn 144
Chandler 124
Beijing 116
Ho Chi Minh City 62
New York 59
Los Angeles 57
Boardman 56
Lauterbourg 55
Munich 51
Redondo Beach 47
Nanjing 42
Shanghai 40
Johannesburg 36
Hanoi 35
Moscow 30
Jacksonville 29
Milan 28
Turku 23
Frankfurt am Main 22
Princeton 22
Helsinki 21
Lawrence 21
Nanchang 21
Wilmington 19
Buffalo 18
Medford 18
Orem 17
Jiaxing 15
Nuremberg 15
Brooklyn 14
São Paulo 14
Warsaw 14
Montreal 13
Toronto 13
London 12
Seattle 12
Boston 11
Changsha 11
Falkenstein 11
Mexico City 11
San Francisco 11
Shenyang 11
Tokyo 11
Haiphong 10
Mumbai 10
Chicago 9
Da Nang 9
Pavia 9
Amsterdam 8
Council Bluffs 8
Düsseldorf 8
Hebei 8
Santa Clara 8
Atlanta 7
Manchester 7
Norwalk 7
Poplar 7
Stockholm 7
Tashkent 7
Brussels 6
Chennai 6
Denver 6
Rio de Janeiro 6
Rome 6
The Dalles 6
Dhaka 5
Guangzhou 5
Hangzhou 5
Phoenix 5
Piscataway 5
Quezon City 5
Tianjin 5
Vienna 5
Ankara 4
Ann Arbor 4
Baghdad 4
Brasília 4
Columbus 4
Curitiba 4
Elk Grove Village 4
Kuala Lumpur 4
Paris 4
Piracicaba 4
Santiago 4
Tallahassee 4
Thái Nguyên 4
Turin 4
Washington 4
Amman 3
Austin 3
Baku 3
Belo Horizonte 3
Biên Hòa 3
Bologna 3
Buenos Aires 3
Totale 2.600
Salva come PNG Salva come JPEG
Nome #
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 129
Barbed suture in minimally invasive hysterectomy: a systematic review and meta-analysis 107
Sexuality in premature ovarian insufficiency 102
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis 96
Bilateral ovarian malakoplakia: Case report and review of the literature with clinical and diagnostic considerations 94
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma 94
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 93
Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies 90
Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer 89
Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women? 89
Robotic single-site hysterectomy: Two institutions' preliminary experience 88
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 88
Robotic single-site surgery in management of obese patients with early-stage endometrial cancer 87
Robotic single-site technique allows pelvic lymphadenectomy in surgical staging of endometrial cancer 86
Different local estrogen therapies for a tailored approach to GSM 85
Robotic single site hysterectomy with bilateral salpingo-oophorectomy in female to male transsexualism. 85
Single-site Versus Multiport Robotic Hysterectomy in Benign Gynecologic Diseases: A Retrospective Evaluation of Surgical Outcomes and Cost Analysis 83
The role of hormone therapy in urogenital health after menopause 83
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors? 81
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 80
Current opinion on bevacizumab on endometrial cancer treatment 80
Oxaliplatin for the treatment of ovarian cancer 80
Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience 76
Veliparib for the treatment of ovarian cancer 75
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 74
The role of fulvestrant in endometrial cancer 68
Robotic single-site surgery for female-to-male transsexuals: preliminary experience. 67
Exploring differences in psychological aspects during pregnancy between cancer survivors and women without a history of cancer 65
Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience 65
Oral contraception use in BRCA gene mutation carriers: information for counselling in routine clinical practice 64
Four pathogenic variants co-occurring in a MINAS early-onset breast cancer 62
Intralymphatic Histiocytosis Associated with Tubo-ovarian High-grade Serous Carcinoma: Case Report and Review of the Literature 61
Menopause and endometriosis 60
Impact of totally implanted venous access port placement on body image in women with breast cancer 58
Insights into the vulvar component of the genitourinary syndrome of menopause (GSM) 58
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 58
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 56
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy 56
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause 54
Multiple human papillomavirus infection and high-grade cervical squamous intraepithelial lesions among women with human immunodeficiency virus: a systematic review and a meta-analysis 53
Long-term risk of malignancy in the neovagina created using colon graft in vaginal agenesis-A case report 52
Intralesional hemorrhage in Krukenberg tumor: A case report and review of the literature 52
The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis 51
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 49
Psychological Well-Being, Prenatal Attachment, and Quality of Early Mother-Infant Interaction: A Pilot Study With a Sample of Mothers With or Without Cancer History 49
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 48
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms 45
Surveillance alone in stage i malignant ovarian germ cell tumors: A MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 43
RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers 43
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 40
Motherhood during or after breast cancer diagnosis: A qualitative study 40
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 38
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): The MITO-9 study 35
Towards Inclusive Communication in Cancer Prevention and Treatment: A Case Study on Italian Informational Materials 35
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 35
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 34
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 33
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 31
Discourses of Prevention: A Multimodal Study of HPV Vaccination Campaigns in Italy 31
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project 31
Ovarian cancer onset across different BRCA mutation types: A view to a more tailored approach for BRCA mutated patients 31
Term pregnancy and mode of delivery 31
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 28
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 23
null 5
Totale 4.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 7 1 1
2021/202294 0 0 6 0 1 5 1 6 7 1 14 53
2022/2023361 28 40 1 17 26 35 0 22 166 3 17 6
2023/2024285 7 38 7 13 10 60 7 16 2 9 16 100
2024/2025965 34 63 12 12 7 78 40 72 252 61 110 224
2025/20262.103 202 160 185 228 305 111 401 100 245 166 0 0
Totale 4.052